Global Head of Clinical Sciences for Oncology/Immuno-oncology
Lisa Mahnke is the Global Head of Clinical Sciences for the Oncology/Immuno-oncology Therapeutic Area at Servier Pharmaceuticals. In this role, Lisa guides early-stage oncology development.
Lisa is a physician and scientist with deep pharmaceutical experience. Over the past 15 years, she has held leadership positions in both large and small pharmaceutical organizations, including Bristol Myers Squibb, Vertex, Merck, and EMD Serono. She also spent time overseeing clinical development for two biotech companies. Her experience expands across pharmacology, early and late stage development for immune and small molecule therapies.
Lisa received her Doctor of Medicine and Doctor of Philosophy in Biochemistry, with a focus on gene rearrangements, from the University of Wisconsin-Madison. She later completed her residency in Internal Medicine, fellowship in Infectious Diseases and a postdoctoral pathway in Molecular Oncology, at Washington University in St. Louis. Lisa attained board certifications and is currently licensed in Medicine with the Commonwealth of Massachusetts.
To learn more about Lisa connect with her on LinkedIn.
More from Servier
Servier Pharmaceuticals is a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.Learn More
Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.Learn More
Servier has a 65-year history of helping provide innovative medicines to patients globally. In the United States, Servier intends to uphold and build upon that history.Learn More